Expanding NGS Capabilities at MIT
Find out how miniaturization of Illumina library preparation — using the latest liquid handling automated equipment — is enabling leading genetic scientists at MIT to ask broader scientific questions
Simulating Heart Disease in a Microplate
Dr. Ben Alsop discusses how his team at UCL has developed a model that simulates reperfusion injury during a heart attack. He explains how they were able to achieve this in a microplate format, and effectively analyze drug response in real time, using the recently launched CLARIOstar platform.
Next-Generation Molecular Technologies
Program Director, Innovative Molecular Analysis Technologies, at the National Cancer Institute, Tony Dickherber, sheds light on the latest tools being developed at NCI to tackle cancer diagnostics and monitoring of disease. He believes these innovations could propel the field into a future where cancer is no longer a killer.
Delving Deeper into DNA
Find out how scientists can now obtain the highest DNA purity and yield from complex mixed samples, using the unique ArrayTape consumable for barcoded assay miniaturization – down to 0.8 µl.
Data Analysis in 3D – Single Nuclei Resolution
As our 3D culturing capabilities have advanced, sophisticated software is required to accurately analyze complex cellular models and manage high volumes of data. Brendan Brinkman, of Olympus Life Sciences, discusses how, with the NoviSight 3D analysis software, scientists can rapidly analyze multi-cell models down to the individual nuclei.
Taking 3D Cell Culture to the Next Level
3D cell culture is a vital tool in translational research. In this video, Bas Trietsch, CTO of MIMETAS, explains how, with its novel miniaturized platforms, scientists are able to simulate and assess barrier functions based on impedance spectroscopy principles.